BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25324987)

  • 1. The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study.
    Kang HC; Ahn SD; Choi DH; Kang MK; Chung WK; Wu HG
    Radiat Oncol J; 2014 Sep; 32(3):156-62. PubMed ID: 25324987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Aloe Vera-Based Cosmeceutical Cream Delays and Mitigates Ionizing Radiation-Induced Dermatitis in Head and Neck Cancer Patients Undergoing Curative Radiotherapy: A Clinical Study.
    Rao S; Hegde SK; Baliga-Rao MP; Palatty PL; George T; Baliga MS
    Medicines (Basel); 2017 Jun; 4(3):. PubMed ID: 28930258
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
    Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
    Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
    Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
    Röper B; Kaisig D; Auer F; Mergen E; Molls M
    Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients.
    Becker-Schiebe M; Mengs U; Schaefer M; Bulitta M; Hoffmann W
    Strahlenther Onkol; 2011 Aug; 187(8):485-91. PubMed ID: 21786113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
    Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
    Boström A; Lindman H; Swartling C; Berne B; Bergh J
    Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cicaderma® in radiation-related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RT.
    Racadot S; Arnaud A; Schiffler C; Metzger S; Pérol D; Kirova Y
    Clin Transl Radiat Oncol; 2023 Jul; 41():100647. PubMed ID: 37441546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
    Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial.
    Togni S; Maramaldi G; Bonetta A; Giacomelli L; Di Pierro F
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1338-44. PubMed ID: 25967706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of recombinant human epidermal growth factor on radiation dermatitis in rectal and anal cancer patients: a self-controlled study.
    Liu S; Wang YL; Shi ST; Zeng GD; Song YW; Zhang XD; Zheng J; Fan XJ; Liu YP
    BMC Cancer; 2022 Nov; 22(1):1140. PubMed ID: 36335306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients.
    Merchant TE; Bosley C; Smith J; Baratti P; Pritchard D; Davis T; Li C; Xiong X
    Radiat Oncol; 2007 Dec; 2():45. PubMed ID: 18093332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
    Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
    Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
    Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
    Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
    Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.
    Chou HL; Shueng PW; Liao LJ; Hsu CX; Kuo DY; Lo WC; Hou PY; Wang LY; Chou SF; Hsieh CH
    Radiat Oncol; 2019 May; 14(1):90. PubMed ID: 31146741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
    Ulff E; Maroti M; Serup J; Falkmer U
    Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study.
    Palatty PL; Azmidah A; Rao S; Jayachander D; Thilakchand KR; Rai MP; Haniadka R; Simon P; Ravi R; Jimmy R; D'souza PF; Fayad R; Baliga MS
    Br J Radiol; 2014 Jun; 87(1038):20130490. PubMed ID: 24694358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.